C07K 16/28 (2006.01) (21) International Application Number
( 2 (51) International Patent Classification: OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, A61K 39/00 (2006.01) C07K 16/28 (2006.01) SC, SD, SE, SG, SK, SL, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, WS, ZA, ZM, ZW. (21) International Application Number: PCT/US2020/033563 (84) Designated States (unless otherwise indicated, for every kind of regional protection available) . ARIPO (BW, GH, (22) International Filing Date: GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, 19 May 2020 (19.05.2020) UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (25) Filing Language: English TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, (26) Publication Language: English MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (30) Priority Data: TR), OAPI (BF, BJ, CF, CG, Cl, CM, GA, GN, GQ, GW, 62/850,889 2 1 May 2019 (21.05.2019) US KM, ML, MR, NE, SN, TD, TG). 62/854,667 30 May 2019 (30.05.2019) US Declarations under Rule 4.17: (71) Applicant: NOVARTIS AG [CH/CH]; Lichtstrassc 35, — as to applicant's entitlement to apply for and be granted a 4056 Basel (CH). patent (Rule 4.17(H)) (71) Applicant (for US only): HUANG, Lu [US/US]; Novartis — as to the applicant's entitlement to claim the priority of the Institutes for BioMedical Research, Inc., 250 Massachusetts earlier application (Rule 4.17(iii)) Avenue, Cambridge, Massachusetts 02139 (US).
[Show full text]